Skip to content
10-Q

Quarterly Report

Edesa Biotech, Inc. EDSA

0001171843-25-005236

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Aug 8, 2025 7.04M sh
Operating Cash Flow Q3 2025 · Jun 30, 2025 −$5.6M
Operating Cash Flow Q3 2025 · Jun 30, 2024 −$3.92M
Cash And Equivalents Q3 2025 · Jun 30, 2025 $12.4M
Stockholders Equity Q3 2025 · Jun 30, 2025 $14.13M
Stockholders Equity Q3 2025 · Mar 31, 2025 $15.54M
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.98M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.87M
Stockholders Equity Q3 2025 · Mar 31, 2024 $4.32M
Stockholders Equity Q3 2025 · Sep 30, 2023 $7.05M
Current Liabilities Q3 2025 · Jun 30, 2025 $672.67K
Current Liabilities Q3 2025 · Sep 30, 2024 $1.83M
Current Assets Q3 2025 · Jun 30, 2025 $12.76M
Current Assets Q3 2025 · Sep 30, 2024 $1.68M
Total Assets Q3 2025 · Jun 30, 2025 $14.8M
Total Assets Q3 2025 · Sep 30, 2024 $3.81M
Eps Basic Q3 2025 · Jun 30, 2025 −$0.25
Eps Basic Q3 2025 · Jun 30, 2025 −$0.95
Eps Basic Q3 2025 · Jun 30, 2024 −$0.52
Eps Basic Q3 2025 · Jun 30, 2024 −$1.64
Sga Expense Q3 2025 · Jun 30, 2025 $964.68K
Sga Expense Q3 2025 · Jun 30, 2025 $3M
Sga Expense Q3 2025 · Jun 30, 2024 $1.04M
Sga Expense Q3 2025 · Jun 30, 2024 $3.23M
Rd Expense Q3 2025 · Jun 30, 2025 $939.07K
Rd Expense Q3 2025 · Jun 30, 2025 $2.44M
Rd Expense Q3 2025 · Jun 30, 2024 $897.31K
Rd Expense Q3 2025 · Jun 30, 2024 $2.78M
Net Income Q3 2025 · Jun 30, 2025 −$1.75M
Net Income Q3 2025 · Jun 30, 2025 −$4.96M
Net Income Q3 2025 · Jun 30, 2024 −$1.67M
Net Income Q3 2025 · Jun 30, 2024 −$5.21M
Operating Income Q3 2025 · Jun 30, 2025 −$1.9M
Operating Income Q3 2025 · Jun 30, 2025 −$5.44M
Operating Income Q3 2025 · Jun 30, 2024 −$1.93M
Operating Income Q3 2025 · Jun 30, 2024 −$6.01M